Literature DB >> 23446518

Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation.

Kengo Furuichi1, Miho Shimizu, Tadashi Toyama, Daisuke Koya, Yoshitaka Koshino, Hideharu Abe, Kiyoshi Mori, Hiroaki Satoh, Masahito Imanishi, Masayuki Iwano, Hiroyuki Yamauchi, Eiji Kusano, Shouichi Fujimoto, Yoshiki Suzuki, Seiya Okuda, Kiyoki Kitagawa, Yasunori Iwata, Shuichi Kaneko, Shinichi Nishi, Hitoshi Yokoyama, Yoshihiko Ueda, Masakazu Haneda, Hirofumi Makino, Takashi Wada.   

Abstract

BACKGROUND: Diabetic nephropathy, leading to end-stage renal disease, has a considerable impact on public health and the social economy. However, there are few national registries of diabetic nephropathy in Japan. The aims of this prospective cohort study are to obtain clinical data and urine samples for revising the clinical staging of diabetic nephropathy, and developing new diagnostic markers for early diabetic nephropathy.
METHODS: The Japanese Society of Nephrology established a nationwide, web-based, and prospective registry system. On the system, there are two basic registries; the Japan Renal Biopsy Registry (JRBR), and the Japan Kidney Disease Registry (JKDR). In addition to the two basic registries, we established a new prospective registry to the system; the Japan Diabetic Nephropathy Cohort Study (JDNCS), which collected physical and laboratory data.
RESULTS: We analyzed the data of 321 participants (106 female, 215 male; average age 65 years) in the JDNCS. Systolic and diastolic blood pressure was 130.1 and 72.3 mmHg, respectively. Median estimated glomerular filtration rate (eGFR) was 33.3 ml/min/1.73 m(2). Proteinuria was 1.8 g/gCr, and serum levels of albumin were 3.6 g/dl. The majority of the JDNCS patients presented with preserved eGFR and low albuminuria or low eGFR and advanced proteinuria. In the JRBR and JKDR registries, 484 and 125 participants, respectively, were enrolled as having diabetes mellitus. In comparison with the JRBR and JKDR registries, the JDNCS was characterized by diabetic patients presenting with low proteinuria with moderately preserved eGFR.
CONCLUSIONS: There are few national registries of diabetic nephropathy to evaluate prognosis in Japan. Future analysis of the JDNCS will provide clinical insights into the epidemiology and renal and cardiovascular outcomes of type 2 diabetic patients in Japan.

Entities:  

Mesh:

Year:  2013        PMID: 23446518     DOI: 10.1007/s10157-013-0778-8

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  10 in total

Review 1.  Clinical impact of albuminuria in diabetic nephropathy.

Authors:  Takashi Wada; Miho Shimizu; Tadashi Toyama; Akinori Hara; Shuichi Kaneko; Kengo Furuichi
Journal:  Clin Exp Nephrol       Date:  2011-08-10       Impact factor: 2.801

2.  Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients.

Authors:  Wing Yee So; Alice P S Kong; Ronald C W Ma; Risa Ozaki; Cheuk Chun Szeto; Norman N Chan; Vanessa Ng; Chung Shun Ho; Christopher W K Lam; Chun Chung Chow; Clive S Cockram; Juliana C N Chan; Peter C Y Tong
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

3.  Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions.

Authors:  M Luiza Caramori; Paola Fioretto; Michael Mauer
Journal:  Diabetes       Date:  2003-04       Impact factor: 9.461

4.  Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study.

Authors:  G Bruno; F Merletti; G Bargero; G Novelli; D Melis; A Soddu; M Perotto; G Pagano; P Cavallo-Perin
Journal:  Diabetologia       Date:  2007-03-02       Impact factor: 10.122

5.  Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan.

Authors:  Hitoshi Sugiyama; Hitoshi Yokoyama; Hiroshi Sato; Takao Saito; Yukimasa Kohda; Shinichi Nishi; Kazuhiko Tsuruya; Hideyasu Kiyomoto; Hiroyuki Iida; Tamaki Sasaki; Makoto Higuchi; Motoshi Hattori; Kazumasa Oka; Shoji Kagami; Michio Nagata; Tetsuya Kawamura; Masataka Honda; Yuichiro Fukasawa; Atsushi Fukatsu; Kunio Morozumi; Norishige Yoshikawa; Yukio Yuzawa; Seiichi Matsuo; Yutaka Kiyohara; Kensuke Joh; Takashi Taguchi; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2011-03-25       Impact factor: 2.801

6.  An overview of regular dialysis treatment in Japan (as of 31 December 2007).

Authors:  Shigeru Nakai; Ikuto Masakane; Takashi Shigematsu; Takayuki Hamano; Kunihiro Yamagata; Yuuzou Watanabe; Noritomo Itami; Satoshi Ogata; Naoki Kimata; Toshio Shinoda; Tetsuo Syouji; Kazuyuki Suzuki; Masatomo Taniguchi; Kenji Tsuchida; Hidetomo Nakamoto; Shinichi Nishi; Hiroshi Nishi; Seiji Hashimoto; Takeshi Hasegawa; Norio Hanafusa; Naohiko Fujii; Seiji Marubayashi; Osamu Morita; Kenji Wakai; Atsushi Wada; Kunitoshi Iseki; Yoshiharu Tsubakihara
Journal:  Ther Apher Dial       Date:  2009-12       Impact factor: 1.762

7.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.

Authors:  Toshiharu Ninomiya; Vlado Perkovic; Bastiaan E de Galan; Sophia Zoungas; Avinesh Pillai; Meg Jardine; Anushka Patel; Alan Cass; Bruce Neal; Neil Poulter; Carl-Erik Mogensen; Mark Cooper; Michel Marre; Bryan Williams; Pavel Hamet; Giuseppe Mancia; Mark Woodward; Stephen Macmahon; John Chalmers
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

8.  Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).

Authors:  Hiroki Yokoyama; Hirohito Sone; Mariko Oishi; Koichi Kawai; Yoshihide Fukumoto; Masashi Kobayashi
Journal:  Nephrol Dial Transplant       Date:  2008-11-04       Impact factor: 5.992

Review 9.  Historical chronology of basic and clinical research in diabetic nephropathy and contributions of Japanese scientists.

Authors:  Jun Wada; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2009-04-11       Impact factor: 2.801

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

  10 in total
  3 in total

1.  Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.

Authors:  Miho Shimizu; Kengo Furuichi; Tadashi Toyama; Tomoaki Funamoto; Shinji Kitajima; Akinori Hara; Daisuke Ogawa; Daisuke Koya; Kenzo Ikeda; Yoshitaka Koshino; Yukie Kurokawa; Hideharu Abe; Kiyoshi Mori; Masaaki Nakayama; Yoshio Konishi; Ken-Ichi Samejima; Masaru Matsui; Hiroyuki Yamauchi; Tomohito Gohda; Kei Fukami; Daisuke Nagata; Hidenori Yamazaki; Yukio Yuzawa; Yoshiki Suzuki; Shouichi Fujimoto; Shoichi Maruyama; Sawako Kato; Takero Naito; Kenichi Yoshimura; Hitoshi Yokoyama; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2017-09-09       Impact factor: 2.801

Review 2.  Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency.

Authors:  Miho Shimizu; Kengo Furuichi; Hitoshi Yokoyama; Tadashi Toyama; Yasunori Iwata; Norihiko Sakai; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-10-01       Impact factor: 2.801

3.  Drug-induced kidney disease: a study of the Japan Renal Biopsy Registry from 2007 to 2015.

Authors:  Hitoshi Yokoyama; Ichie Narita; Hitoshi Sugiyama; Michio Nagata; Hiroshi Sato; Yoshihiko Ueda; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2015-11-21       Impact factor: 2.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.